Premium
CT colonography for postoperative surveillance after curative gastrectomy in patients with gastric cancer
Author(s) -
Lim Joon Seok,
Lee Sang Kil,
Hyung Woo Jin,
Choi JinYoung,
Kim MyeongJin,
Noh Sung Hoon,
Kim Ki Whang
Publication year - 2010
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21650
Subject(s) - medicine , gastrectomy , cancer , radiology , general surgery , surgery , gastroenterology
Aim The purpose was to evaluate the diagnostic role of contrast‐enhanced CT colonography (CTC) for follow‐up of colorectal cancer screening after curative gastrectomy in patients with gastric adenocarcinomas. Materials and Methods Contrast‐enhanced CTC was performed as a substitute for routine follow‐up CT for the detection of recurrent lesions in 700 consecutive patients who underwent curative surgery for gastric adenocarcinomas. Prospectively, patients with polyps measuring 6 mm or larger on CTC were referred for optical colonoscopy. Clinical and radiologic follow‐up with respect to detection of polyp and recurrent lesion was retrospectively assessed. Results Colorectal polyps measuring 6 mm or larger were identified by CTC in 104 (14.9%) of the 700 patients. Optical colonoscopy was recommended to these patients and was performed in 72 cases. True positive lesions were identified in 62 of the 72 patients (per‐patient positive predictive value: 86.1%). The diagnostic yield for primary colonic malignancies was 1.6% (11/700). Recurrent lesions of gastric cancer were also detected in eight patients (1.1%). Conclusion In patients who undergo gastrectomy due to gastric adenocarcinoma, contrast‐enhanced CTC may offer a unique advantage by allowing simultaneous colorectal cancer screening in addition to its routine role of detecting recurrent lesions during follow‐up. J. Surg. Oncol. 2010;102:593–598. © 2010 Wiley‐Liss, Inc.